Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial- Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2688
https://www.valueinhealthjournal.com/article/S1098-3015(15)04764-6/fulltext
Title : Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial- Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04764-6&doi=10.1016/j.jval.2015.09.2688
First page : A713
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 2095
Categories :
Tags :
Regions :
ViH Article Tags :